Featured News
428NewsFHA-HoReCa announces new initiatives and partnerships for 2024 edition, covering Technology Solutions and Talent recognition
Anticipate the debut of first-ever FSTEC Asia – catering to the surging demand for technology solutions among APAC restaurant companies – from...
- 632Wire Stories
ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer
Approval based on DESTINY-Lung02 trial results where Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a confirmed objective response rate of 49.0% and median...
- 470Wire Stories
Bias in AI Computer Vision Systems Dramatically Reduced with Synthetic Data ‘Digital Humans’
Mindtech’s Digital DNA technology creates a diverse range of Digital Humans that allow for statistically fair representation of the eight billion real...
- 441Wire Stories
APO’s Newest Member Turkiye Hosts 64th Workshop Meeting of Heads of National Productivity Organizations
ANKARA, Turkiye–(BUSINESS WIRE)–#APO–Turkiye, the Asian Productivity Organization’s (APO’s) newest member, generously hosted the 64th Workshop Meeting (WSM) of Heads of National Productivity...
- 1.2KNews
MindHub Academy 與廣州VV ARTç¶ç¶è—術創作åˆä½œ
MindHub Academy 與廣州VV ARTç¶ç¶è—術創作åˆä½œï¼ŒæŽ¨å‡ºå¤šæ¨£è—術課程，啟發創æ„æ–°æ½®æµ é¦™æ¸¯ – Media OutReach – 2023å¹´10月23æ—¥ – 在這個充滿活力的城市，一個令人振奮的消æ¯å³å°‡åœ¨è—術界掀起巨浪。MindHub Academy 和⌈廣州VV ARTç¶ç¶è—術創作 ⌋åˆä½œï¼ŒMindHub Academy是一家致力於æ供高質é‡æ•™è‚²å’Œè—術培訓的機構，而廣州VV ARTç¶ç¶è—術創作是一家充滿活力且經驗è±å¯Œçš„è—術機構。這兩家機構的åˆä½œæ¨™èªŒè‘—一個令人振奮的時刻，å³å°‡ç‚ºè—術愛好者ã€å‰µæ„éˆæ„Ÿè¿¸ç™¼è€…以åŠå‰µæ„åˆå¸è€…å¸¶ä¾†ä¸€å ´å‰æ‰€æœªæœ‰çš„è—術之旅。這個令人期待的åˆä½œå°‡æä¾›å¸ç”Ÿå€‘機會åƒèˆ‡å’Œè«§ç²‰å½©èª²ç¨‹ã€æ²™ç•«èª²ç¨‹ï¼ŒåŒæ™‚也推出襌繞畫課程ã€æµé«”畫課程ã€æ²™ç•«å·¥ä½œåŠã€å’Œè—術工作åŠç‰å¤šæ¨£èª²ç¨‹ã€‚MindHub Academyå°‡é‡æ–°å®šç¾©è—術教育，啟發新的潮æµï¼Œä¸¦ç‚ºæ¯å€‹åƒèˆ‡è€…打開創æ„的大門。 MindHub Academyé¸æ“‡ä¾†åˆ°å»£å·žåƒåŠ ⌈VV ARTç¶ç¶è—術創作...
- 460Wire Stories
Covation Holdings Continues Expansion in Asia Pacific With New Regional Corporate Headquarters
HONG KONG–(BUSINESS WIRE)–Covation Holdings Limited, the global manufacturer of multiple wheeled goods brands, today announced the addition of a new global corporate...
- 454Wire Stories
Berkshire Hathaway Specialty Insurance Names Sami Jaghbir as Underwriting Manager in Queensland
BRISBANE, Australia & BOSTON–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has appointed Sami Jaghbir as Underwriting Manager, Queensland. “Sami...
- 546Wire Stories
Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer
– Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus pembrolizumab compared to chemotherapy – – Enfortumab...
- 462Wire Stories
Raludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial
Encouraging overall response rate of 46% and disease control rate of 98% with a median duration of response of 11.2 months seen...
- 454News
Correcting and Replacing: Lighting the Way to the Future: Renowned Brands Unveil Breakthroughs in the World-Renowned Lighting Marketplace
Buyer Registration Link HONG KONG SAR – Media OutReach – 22 October 2023 – Organised by the Hong Kong Trade Development Council...
- 580Wire Stories
Datopotamab Deruxtecan Plus Durvalumab Demonstrated Robust and Durable Tumor Responses in First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer in BEGONIA Phase 1b/2 Trial
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab showed a confirmed objective response rate of 79% Two ongoing phase 3 trials are...
